The State of Pharmaceutical Quality FY21
Introduction On August 25th, the Office of Pharmaceutical Quality (OPQ), part of the FDA’s Center for Drug Evaluation and Research (CDER) released its fourth annual Report on the State of Pharmaceutical Quality, covering fiscal year 2021. Generally speaking, the OPQ is tasked with ensuring that legally marketed drugs in the US are safe, effective, and […]